Delivery Order SPE2DB22D2108-SPE2DB23FU3RT
- Not listed
- This federal contract award is for the delivery of 4,566,132,482 units of Citalopram HBR 20 mg tablets to the Defense Logistics Agency (DLA). The $3,376.23 fixed-price delivery order was awarded to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,914.85 firm fixed-price delivery order is for the supply of 4,566,554,867 units of Citalopram HBr 20 mg tablets to support military healthcare programs. The contract has an ultimate completion date of November 27, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,473,890 units of Citalopram HBR 40 mg tablets. The fixed-price delivery order has a ceiling value of $28,331.92 and an ultimate completion date of October 16, 2023. This award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,958.23, is a delivery order for 4,562,704,033 units of Citalopram HBR 40 mg tablets. The contract has a firm fixed price and an ultimate completion date of November 6, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,337.32 firm fixed-price delivery order is for the supply of 4,567,476,935 units of Citalopram HBR 40 mg tablets. The contract has an ultimate completion date of March 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of 4,563,905,445 units of Citalopram HBR 20 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $9,099.76 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a performance period through March 11, 2024 and was not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,680,284 units of Citalopram HBR 40 mg tablets. The $3,805.46 firm fixed-price Delivery Order has a completion date of February 16, 2024 and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that provides a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,873,036 units of the medication Citalopram HBR 40 mg tablets. The award, valued at $2,021.86, is a Firm Fixed Price Delivery Order with a completion date of November 22, 2023. The contract was not set aside for any specific program or business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,756,354 units of Citalopram HBR 40 mg tablets. The Firm Fixed Price delivery order, valued at $1,997.07, has an ultimate completion date of August 10, 2023. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in the System for Award Management (SAM.gov). The contract award is not...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,728.86, is for the delivery of 4562867824 units of Citalopram HBR 40 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of November 21, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB23FU3RTDelivery Order
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $6,062.81 with a completion date of April 26, 2023. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,560,712,462 units of Citalopram HBR 20 mg tablets. The contract is a firm fixed-price award and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 4/25/23 |